PMID- 38334606 OWN - NLM STAT- MEDLINE DCOM- 20240214 LR - 20240214 IS - 2073-4409 (Electronic) IS - 2073-4409 (Linking) VI - 13 IP - 3 DP - 2024 Jan 24 TI - Moderate Elevation of Homocysteine Induces Endothelial Dysfunction through Adaptive UPR Activation and Metabolic Rewiring. LID - 10.3390/cells13030214 [doi] LID - 214 AB - Elevation of the intermediate amino acid metabolite Homocysteine (Hcy) causes Hyperhomocysteinemia (HHcy), a metabolic disorder frequently associated with mutations in the methionine-cysteine metabolic cycle as well as with nutritional deficiency and aging. The previous literature suggests that HHcy is a strong risk factor for cardiovascular diseases. Severe HHcy is well-established to correlate with vascular pathologies primarily via endothelial cell death. Though moderate HHcy is more prevalent and associated with an increased risk of cardiovascular abnormalities in later part of life, its precise role in endothelial physiology is largely unknown. In this study, we report that moderate elevation of Hcy causes endothelial dysfunction through impairment of their migration and proliferation. We established that unlike severe elevation of Hcy, moderate HHcy is not associated with suppression of endothelial VEGF/VEGFR transcripts and ROS induction. We further showed that moderate HHcy induces a sub-lethal ER stress that causes defective endothelial migration through abnormal actin cytoskeletal remodeling. We also found that sub-lethal increase in Hcy causes endothelial proliferation defect by suppressing mitochondrial respiration and concomitantly increases glycolysis to compensate the consequential ATP loss and maintain overall energy homeostasis. Finally, analyzing a previously published microarray dataset, we confirmed that these hallmarks of moderate HHcy are conserved in adult endothelial cells as well. Thus, we identified adaptive UPR and metabolic rewiring as two key mechanistic signatures in moderate HHcy-associated endothelial dysfunction. As HHcy is clinically associated with enhanced vascular inflammation and hypercoagulability, identifying these mechanistic pathways may serve as future targets to regulate endothelial function and health. FAU - Chatterjee, Barun AU - Chatterjee B AUID- ORCID: 0000-0001-6081-0855 AD - CSIR-Institute of Genomics & Integrative Biology, New Delhi 110025, India. AD - Academy of Scientific & Innovative Research, Ghaziabad 201002, India. FAU - Fatima, Fabeha AU - Fatima F AD - CSIR-Institute of Genomics & Integrative Biology, New Delhi 110025, India. FAU - Seth, Surabhi AU - Seth S AD - CSIR-Institute of Genomics & Integrative Biology, New Delhi 110025, India. AD - Academy of Scientific & Innovative Research, Ghaziabad 201002, India. FAU - Sinha Roy, Soumya AU - Sinha Roy S AD - CSIR-Institute of Genomics & Integrative Biology, New Delhi 110025, India. AD - Academy of Scientific & Innovative Research, Ghaziabad 201002, India. LA - eng GR - BSC0122/Council of Scientific and Industrial Research/ PT - Journal Article DEP - 20240124 PL - Switzerland TA - Cells JT - Cells JID - 101600052 RN - 0LVT1QZ0BA (Homocysteine) SB - IM MH - Humans MH - Endothelial Cells/metabolism MH - Homocysteine/metabolism MH - Cell Death MH - *Vascular Diseases/metabolism MH - *Cardiovascular Diseases/metabolism PMC - PMC10854856 OTO - NOTNLM OT - ER stress OT - TCA cycle OT - actin cytoskeleton OT - angiogenesis OT - endothelial cell OT - glycolysis OT - homocysteine OT - mitochondria OT - zebrafish COIS- The authors declare no conflict of interest. EDAT- 2024/02/09 12:44 MHDA- 2024/02/10 14:43 PMCR- 2024/01/24 CRDT- 2024/02/09 10:14 PHST- 2023/11/06 00:00 [received] PHST- 2023/11/25 00:00 [accepted] PHST- 2024/02/10 14:43 [medline] PHST- 2024/02/09 12:44 [pubmed] PHST- 2024/02/09 10:14 [entrez] PHST- 2024/01/24 00:00 [pmc-release] AID - cells13030214 [pii] AID - cells-13-00214 [pii] AID - 10.3390/cells13030214 [doi] PST - epublish SO - Cells. 2024 Jan 24;13(3):214. doi: 10.3390/cells13030214.